Veriphi Shareholder Update: 16 June 2017

Auckland Hospital Preliminary Trials 100% Successful.  As discussed in our 10 June Update, yesterday we conducted our first blind trials with our new analyser, on 5 anaesthetic drugs and solutions, at Auckland City Hospital Department of Anaesthesia. The purpose of the trials was to assess the impact of transporting our new analyser to a different location and conducting tests in a different environment, prior to commencing the formal oncology trial programme at the hospital pharmacy. The drugs and solutions chosen were ones that we could normally expect to be easily discriminated from each other.  Each drug was tested three times, so a total of 15 tests. In 100% of the tests the drugs were correctly verified.